v3.26.1
Share-based Issuances (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of stock option activity
        
   Options   Weighted Average Exercise Price 
Outstanding - December 31, 2025   17,640   $79.66 
Granted        
Forfeited/canceled        
Exercised        
Outstanding – March 31, 2026   17,640   $79.66 

 

         
   Options   Weighted Average Exercise Price 
Outstanding - December 31, 2024   4,480   $990.71 
Granted        
Forfeited/canceled        
Exercised        
Outstanding – March 31, 2025   4,480   $990.71 
Schedule of options outstanding and exercisable
                    
   Options Outstanding**   Options Exercisable** 
Exercise Prices  Number   Price   Life*   Number   Price* 
$14.94   13,564   $14.94    9.45    5,203   $14.94 
$66.75   3,821   $66.75    8.76    3,821   $66.75 
$818.13   144   $818.13    7.71    71   $818.13 
$1,295.91   16   $1,295.91    7.19    8   $1,295.91 
$5,857.78   43   $5,857.78    5.88    43   $5,857.78 
$9,130.28   20   $9,130.28    5.37    20   $9,130.28 
$9,475.72   16   $9,475.72    1.84    16   $9,475.72 
$13,927.65   16   $13,927.65    3.38    16   $13,927.65 
Total – March 31, 2026   17,640              9,198      

 

* Price and Life reflect the weighted average exercise price and weighted average remaining contractual life, respectively.
** The Company’s common stock outstanding as of March 31, 2026 and December 31, 2025 has been retroactively restated for the effect of the 1-for 7.7 reverse stock split effective March 31, 2026.
Schedule of restricted stock units outstanding
        
  

Restricted Stock

Units

  

Weighted Average

Grant Date

Fair Value

 
Outstanding - December 31, 2024   41   $7,398.47 
Granted        
Forfeited/canceled        
Vested/issued   (41)   7,398.47 
Outstanding – March 31, 2025      $